Global Oncolytic Virus Therapy Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Oncolytic Virus Therapy will have significant change from previous year. By the most conservative estimates of global Oncolytic Virus Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5 million in 2020. Over the next five years the Oncolytic Virus Therapy market will register a 25.8% CAGR in terms of revenue, the global market size will reach US$ 12 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Therapy Market Size 2016-2026
2.1.2 Oncolytic Virus Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Oncolytic Virus Therapy Segment by Type
2.2.1 HSV-based Oncolytic Viruses
2.2.2 HSV-based Oncolytic Viruses
2.2.3 Vaccinia Virus-based Oncolytic Viruses
2.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.2.5 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy Market Size by Type
2.3.1 Global Oncolytic Virus Therapy Market Size CAGR by Type
2.3.2 Global Oncolytic Virus Therapy Market Size Market Share by Type (2016-2021)
2.4 Oncolytic Virus Therapy Segment by Application
2.4.1 Melanoma
2.4.2 Prostate Cancer
2.4.3 Breast Cancer
2.4.4 Ovarian Cancer
2.4.5 Others
2.5 Oncolytic Virus Therapy Market Size by Application
2.5.1 Global Oncolytic Virus Therapy Market Size CAGR by Application
2.5.2 Global Oncolytic Virus Therapy Market Size Market Share by Application (2016-2021)
3 Oncolytic Virus Therapy Market Size by Players
3.1 Oncolytic Virus Therapy Market Size Market Share by Players
3.1.1 Global Oncolytic Virus Therapy Revenue by Players (2019-2021E)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Oncolytic Virus Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oncolytic Virus Therapy by Regions
4.1 Oncolytic Virus Therapy Market Size by Regions (2016-2021)
4.2 Americas Oncolytic Virus Therapy Market Size Growth (2016-2021)
4.3 APAC Oncolytic Virus Therapy Market Size Growth (2016-2021)
4.4 Europe Oncolytic Virus Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Oncolytic Virus Therapy Market Size Growth (2016-2021)
5 Americas
5.1 Americas Oncolytic Virus Therapy Market Size by Country (2016-2021)
5.2 Americas Oncolytic Virus Therapy Market Size by Type (2016-2021)
5.3 Americas Oncolytic Virus Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Therapy Market Size by Region (2016-2021)
6.2 APAC Oncolytic Virus Therapy Market Size by Type (2016-2021)
6.3 APAC Oncolytic Virus Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oncolytic Virus Therapy by Country (2016-2021)
7.2 Europe Oncolytic Virus Therapy Market Size by Type (2016-2021)
7.3 Europe Oncolytic Virus Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncolytic Virus Therapy by Region (2016-2021)
8.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Oncolytic Virus Therapy Market Forecast
10.1 Global Oncolytic Virus Therapy Forecast by Regions (2021-2026)
10.1.1 Global Oncolytic Virus Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Oncolytic Virus Therapy Forecast
10.1.3 APAC Oncolytic Virus Therapy Forecast
10.1.4 Europe Oncolytic Virus Therapy Forecast
10.1.5 Middle East & Africa Oncolytic Virus Therapy Forecast
10.2 Americas Oncolytic Virus Therapy Forecast by Countries (2021-2026)
10.2.1 United States Oncolytic Virus Therapy Market Forecast
10.2.2 Canada Oncolytic Virus Therapy Market Forecast
10.2.3 Mexico Oncolytic Virus Therapy Market Forecast
10.2.4 Brazil Oncolytic Virus Therapy Market Forecast
10.3 APAC Oncolytic Virus Therapy Forecast by Region (2021-2026)
10.3.1 China Oncolytic Virus Therapy Market Forecast
10.3.2 Japan Oncolytic Virus Therapy Market Forecast
10.3.3 Korea Oncolytic Virus Therapy Market Forecast
10.3.4 Southeast Asia Oncolytic Virus Therapy Market Forecast
10.3.5 India Oncolytic Virus Therapy Market Forecast
10.3.6 Australia Oncolytic Virus Therapy Market Forecast
10.4 Europe Oncolytic Virus Therapy Forecast by Country (2021-2026)
10.4.1 Germany Oncolytic Virus Therapy Market Forecast
10.4.2 France Oncolytic Virus Therapy Market Forecast
10.4.3 UK Oncolytic Virus Therapy Market Forecast
10.4.4 Italy Oncolytic Virus Therapy Market Forecast
10.4.5 Russia Oncolytic Virus Therapy Market Forecast
10.5 Middle East & Africa Oncolytic Virus Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Oncolytic Virus Therapy Market Forecast
10.5.2 South Africa Oncolytic Virus Therapy Market Forecast
10.5.3 Israel Oncolytic Virus Therapy Market Forecast
10.5.4 Turkey Oncolytic Virus Therapy Market Forecast
10.5.5 GCC Countries Oncolytic Virus Therapy Market Forecast
10.6 Global Oncolytic Virus Therapy Forecast by Type (2021-2026)
10.7 Global Oncolytic Virus Therapy Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Oncolytic Virus Therapy Product Offered
11.1.3 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Information
11.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Offered
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Oncolytics Biotech Main Business Overview
11.2.5 Oncolytics Biotech Latest Developments
11.3 Viralytics
11.3.1 Viralytics Company Information
11.3.2 Viralytics Oncolytic Virus Therapy Product Offered
11.3.3 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Viralytics Main Business Overview
11.3.5 Viralytics Latest Developments
11.4 Transgene SA
11.4.1 Transgene SA Company Information
11.4.2 Transgene SA Oncolytic Virus Therapy Product Offered
11.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Transgene SA Main Business Overview
11.4.5 Transgene SA Latest Developments
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Information
11.5.2 Oncolys BioPharma Oncolytic Virus Therapy Product Offered
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Oncolys BioPharma Main Business Overview
11.5.5 Oncolys BioPharma Latest Developments
11.6 Targovax
11.6.1 Targovax Company Information
11.6.2 Targovax Oncolytic Virus Therapy Product Offered
11.6.3 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Targovax Main Business Overview
11.6.5 Targovax Latest Developments
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Information
11.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Offered
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 PsiOxus Therapeutics Main Business Overview
11.7.5 PsiOxus Therapeutics Latest Developments
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Information
11.8.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offered
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 SillaJen Biotherapeutics Main Business Overview
11.8.5 SillaJen Biotherapeutics Latest Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Offered
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Sorrento Therapeutics Main Business Overview
11.9.5 Sorrento Therapeutics Latest Developments
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Information
11.10.2 Lokon Pharma Oncolytic Virus Therapy Product Offered
11.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Lokon Pharma Main Business Overview
11.10.5 Lokon Pharma Latest Developments
11. Genelux Corporation
11.11.1 Genelux Corporation Company Information
11.11.2 Genelux Corporation Oncolytic Virus Therapy Product Offered
11.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Genelux Corporation Main Business Overview
11.11.5 Genelux Corporation Latest Developments
11.12 Vyriad
11.12.1 Vyriad Company Information
11.12.2 Vyriad Oncolytic Virus Therapy Product Offered
11.12.3 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Vyriad Main Business Overview
11.12.5 Vyriad Latest Developments
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Information
11.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Offered
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 TILT Biotherapeutics Main Business Overview
11.13.5 TILT Biotherapeutics Latest Developments
11.14 Cold Genesys
11.14.1 Cold Genesys Company Information
11.14.2 Cold Genesys Oncolytic Virus Therapy Product Offered
11.14.3 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Cold Genesys Main Business Overview
11.14.5 Cold Genesys Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Oncolytic Virus Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of HSV-based Oncolytic Viruses
Table 3. Major Players of Adenoviruses-based Oncolytic Viruses
Table 4. Major Players of Vaccinia Virus-based Oncolytic Viruses
Table 5. Major Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
Table 6. Major Players of Newcastle Disease Virus-based Oncolytic Viruses
Table 7. Oncolytic Virus Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 8. Global Oncolytic Virus Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 9. Global Oncolytic Virus Therapy Market Size Market Share by Type (2016-2021)
Table 10. Oncolytic Virus Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 11. Global Oncolytic Virus Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 12. Global Oncolytic Virus Therapy Market Size Market Share by Application (2016-2021)
Table 13. Global Oncolytic Virus Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 14. Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2021E)
Table 15. Oncolytic Virus Therapy Key Players Head office and Products Offered
Table 16. Oncolytic Virus Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncolytic Virus Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 20. Global Oncolytic Virus Therapy Market Size Market Share by Regions 2016-2021
Table 21. Americas Oncolytic Virus Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 22. Americas Oncolytic Virus Therapy Market Size Market Share by Country (2016-2021)
Table 23. Americas Oncolytic Virus Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 24. Americas Oncolytic Virus Therapy Market Size Market Share by Type (2016-2021)
Table 25. Americas Oncolytic Virus Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 26. Americas Oncolytic Virus Therapy Market Size Market Share by Application (2016-2021)
Table 27. APAC Oncolytic Virus Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 28. APAC Oncolytic Virus Therapy Market Size Market Share by Region (2016-2021)
Table 29. APAC Oncolytic Virus Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 30. APAC Oncolytic Virus Therapy Market Size Market Share by Type (2016-2021)
Table 31. APAC Oncolytic Virus Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 32. APAC Oncolytic Virus Therapy Market Size Market Share by Application (2016-2021)
Table 33. Europe Oncolytic Virus Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 34. Europe Oncolytic Virus Therapy Market Size Market Share by Country (2016-2021)
Table 35. Europe Oncolytic Virus Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 36. Europe Oncolytic Virus Therapy Market Size Market Share by Type (2016-2021)
Table 37. Europe Oncolytic Virus Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 38. Europe Oncolytic Virus Therapy Market Size Market Share by Application (2016-2021)
Table 39. Middle East & Africa Oncolytic Virus Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Region (2016-2021)
Table 41. Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Type (2016-2021)
Table 43. Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Application (2016-2021)
Table 45. Key and Potential Regions of Oncolytic Virus Therapy
Table 46. Key Application and Potential Industries of Oncolytic Virus Therapy
Table 47. Key Challenges of Oncolytic Virus Therapy
Table 48. Key Trends of Oncolytic Virus Therapy
Table 49. Global Oncolytic Virus Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 50. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 51. Global Oncolytic Virus Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 52. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 53. Global Oncolytic Virus Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 54. Global Oncolytic Virus Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 55. Amgen Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 56. Amgen Oncolytic Virus Therapy Product Offered
Table 57. Amgen Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 58. Amgen Main Business
Table 59. Amgen Latest Developments
Table 60. Oncolytics Biotech Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 61. Oncolytics Biotech Oncolytic Virus Therapy Product Offered
Table 62. Oncolytics Biotech Main Business
Table 63. Oncolytics Biotech Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 64. Oncolytics Biotech Latest Developments
Table 65. Viralytics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 66. Viralytics Oncolytic Virus Therapy Product Offered
Table 67. Viralytics Main Business
Table 68. Viralytics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. Viralytics Latest Developments
Table 70. Transgene SA Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 71. Transgene SA Oncolytic Virus Therapy Product Offered
Table 72. Transgene SA Main Business
Table 73. Transgene SA Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. Transgene SA Latest Developments
Table 75. Oncolys BioPharma Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 76. Oncolys BioPharma Oncolytic Virus Therapy Product Offered
Table 77. Oncolys BioPharma Main Business
Table 78. Oncolys BioPharma Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. Oncolys BioPharma Latest Developments
Table 80. Targovax Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 81. Targovax Oncolytic Virus Therapy Product Offered
Table 82. Targovax Main Business
Table 83. Targovax Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. Targovax Latest Developments
Table 85. PsiOxus Therapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 86. PsiOxus Therapeutics Oncolytic Virus Therapy Product Offered
Table 87. PsiOxus Therapeutics Main Business
Table 88. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. PsiOxus Therapeutics Latest Developments
Table 90. SillaJen Biotherapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 91. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Offered
Table 92. SillaJen Biotherapeutics Main Business
Table 93. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. SillaJen Biotherapeutics Latest Developments
Table 95. Sorrento Therapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 96. Sorrento Therapeutics Oncolytic Virus Therapy Product Offered
Table 97. Sorrento Therapeutics Main Business
Table 98. Sorrento Therapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. Sorrento Therapeutics Latest Developments
Table 100. Lokon Pharma Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 101. Lokon Pharma Oncolytic Virus Therapy Product Offered
Table 102. Lokon Pharma Main Business
Table 103. Lokon Pharma Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 104. Lokon Pharma Latest Developments
Table 105. Genelux Corporation Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 106. Genelux Corporation Oncolytic Virus Therapy Product Offered
Table 107. Genelux Corporation Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 108. Genelux Corporation Main Business
Table 109. Genelux Corporation Latest Developments
Table 110. Vyriad Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 111. Vyriad Oncolytic Virus Therapy Product Offered
Table 112. Vyriad Main Business
Table 113. Vyriad Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 114. Vyriad Latest Developments
Table 115. TILT Biotherapeutics Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 116. TILT Biotherapeutics Oncolytic Virus Therapy Product Offered
Table 117. TILT Biotherapeutics Main Business
Table 118. TILT Biotherapeutics Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 119. TILT Biotherapeutics Latest Developments
Table 120. Cold Genesys Details, Company Type, Oncolytic Virus Therapy Area Served and Its Competitors
Table 121. Cold Genesys Oncolytic Virus Therapy Product Offered
Table 122. Cold Genesys Main Business
Table 123. Cold Genesys Oncolytic Virus Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 124. Cold Genesys Latest Developments
List of Figures
Figure 1. Oncolytic Virus Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Oncolytic Virus Therapy Market Size Market Share by Type in 2020
Figure 7. Oncolytic Virus Therapy in Melanoma
Figure 8. Global Oncolytic Virus Therapy Market: Melanoma (2016-2021) & ($ Millions)
Figure 9. Oncolytic Virus Therapy in Prostate Cancer
Figure 10. Global Oncolytic Virus Therapy Market: Prostate Cancer (2016-2021) & ($ Millions)
Figure 11. Oncolytic Virus Therapy in Breast Cancer
Figure 12. Global Oncolytic Virus Therapy Market: Breast Cancer (2016-2021) & ($ Millions)
Figure 13. Oncolytic Virus Therapy in Ovarian Cancer
Figure 14. Global Oncolytic Virus Therapy Market: Ovarian Cancer (2016-2021) & ($ Millions)
Figure 15. Oncolytic Virus Therapy in Others
Figure 16. Global Oncolytic Virus Therapy Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Oncolytic Virus Therapy Market Size Market Share by Application in 2020
Figure 18. Global Oncolytic Virus Therapy Revenue Market Share by Player in 2020
Figure 19. Global Oncolytic Virus Therapy Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Oncolytic Virus Therapy Market Size 2016-2021 ($ Millions)
Figure 21. APAC Oncolytic Virus Therapy Market Size 2016-2021 ($ Millions)
Figure 22. Europe Oncolytic Virus Therapy Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Oncolytic Virus Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Americas Oncolytic Virus Therapy Market Size Market Share by Country in 2020
Figure 25. Americas Oncolytic Virus Therapy Market Size Market Share by Type in 2020
Figure 26. Americas Oncolytic Virus Therapy Market Size Market Share by Application in 2020
Figure 27. United States Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Oncolytic Virus Therapy Market Size Market Share by Regions in 2020
Figure 31. APAC Oncolytic Virus Therapy Market Size Market Share by Type in 2020
Figure 32. APAC Oncolytic Virus Therapy Market Size Market Share by Application in 2020
Figure 33. China Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Oncolytic Virus Therapy Market Size Market Share by Country in 2020
Figure 40. Europe Oncolytic Virus Therapy Market Size Market Share by Type in 2020
Figure 41. Europe Oncolytic Virus Therapy Market Size Market Share by Application in 2020
Figure 42. Germany Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Oncolytic Virus Therapy Market Size Market Share by Application in 2020
Figure 50. Egypt Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Oncolytic Virus Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 56. APAC Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 57. Europe Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 59. United States Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Canada Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 63. China Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Japan Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 65. Korea Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 67. India Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Australia Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 69. Germany Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 70. France Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 71. UK Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 72. Italy Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 73. Russia Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Spain Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 77. Israel Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Oncolytic Virus Therapy Market Size 2021-2026 ($ Millions)
